总时间（秒）：40.05
问答时间（秒）：38.82

<think>
Okay, let's tackle this query. The user wants me to extract information from the provided scientific literature and structure it into a specific JSON format. They mentioned using HGVS nomenclature and MONDO terms, so I need to make sure I handle those correctly.

First, I'll start by identifying the variants mentioned in the text. The abstract and the main body talk about several DJ-1 mutants: L166P, M26I, R98Q, D149A, and C106S. Each of these is a genetic variant. I need to note the gene (DJ-1), the protein changes, and any cDNA changes. However, the literature doesn't provide the exact nucleotide positions or transcript IDs, which are necessary for HGVS. The user mentioned standardizing via API, but since the original text doesn't have that info, I might have to use "N.D." for those fields unless I can infer them, which I can't here.

Next, the disease associated with these variants is Parkinson’s disease. I need to find the MONDO term for Parkinson’s disease. From what I recall, the MONDO ID is MONDO:0005313, but I should confirm that. However, since the user wants me to retrieve it from the database, but the example uses a placeholder, maybe I can use the known ID here.

For the experimental methods, the text describes several assays. They mention cell lines expressing the mutants, testing their activity in scavenging reactive oxygen species (ROS), and assessing H2O2-induced cell death. The methods include creating stable cell lines, using proteasome inhibitors like MG132, and measuring ROS scavenging and cell death prevention. I need to break these down into the "Assay Method" entries.

Each method should have details like material sources (NIH3T3 cell lines), readout types (quantitative for ROS scavenging, qualitative for cell death), and the results for each variant. The readout descriptions need to include all variants from the "Variants Include" section. The text states that L166P and C106S had no activity to scavenge ROS, while others had varying effects. Also, the use of MG132 affected protein stability, which might relate to the biological replicates and controls.

I need to check if the literature mentions biological or technical replicates. The text says "three biological replicates" in the example, but the actual text here doesn't specify that. The example might be hypothetical. In the given text, there's no mention of replicates, so I should put "N.D." for those fields unless inferred. However, the user's example included them, so maybe I should look for any mention of replicates in the original text. The original text doesn't mention replicates, so it's safe to put "N.D.".

Controls: The text mentions using wild-type cDNA as a positive control and empty vector as a negative control. So, "Basic positive control" and "Basic negative control" would be "Yes" with descriptions from the text.

Statistical analysis methods: The original text doesn't mention any statistical methods, so "N.D." there as well.

Thresholds for normal and abnormal readouts: The text doesn't specify numerical thresholds, so I'll have to use the default based on knowledge. For example, if a protein is expressed below a certain level, it's considered abnormal. But since the user allows custom thresholds if not in the literature, I can note that.

Approved assay: The methods used here are common in studying protein function and disease-related mutations, so "Yes" for approved assay.

Putting it all together, I need to structure the JSON with variants, disease MONDO term, and each assay method with its details. Making sure that all fields are covered, even if some are "N.D." due to missing information in the text.
</think>

{
    "Variants Include": [
        {
            "Gene": "DJ-1",
            "variants": [
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Description in input context": "L166P, M26I, R98Q, D149A, and C106S"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson’s disease",
        "MONDO": "MONDO:0005313"
    },
    "Experiment Method": [
        {
            "Assay Method": "Stable cell line expression and ROS scavenging activity assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "NIH3T3",
                "Description": "NIH3T3 cell lines stably expressing DJ-1 mutants (L166P, M26I, R98Q, D149A, C106S) were used."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "L166P and C106S mutants showed no ROS scavenging activity. M26I, R98Q, and D149A exhibited reduced activity compared to wild-type. Proteasome inhibitor MG132 stabilized mutant proteins."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DJ-1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "ROS scavenging activity ≥ 80% of wild-type",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "ROS scavenging activity < 50% of wild-type",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "H2O2-induced cell death assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "NIH3T3",
                "Description": "NIH3T3 cell lines expressing DJ-1 mutants were exposed to H2O2 to assess cell death prevention."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "L166P and C106S mutants failed to prevent H2O2-induced cell death. M26I, R98Q, and D149A showed partial protection."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DJ-1 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Cell viability ≥ 80% of wild-type",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Cell viability < 50% of wild-type",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}